OptimizeRx Corporation (OPRX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

OptimizeRx Corporation (OPRX) is down 59.6% since the beginning of the year. At $5 per share, OPRX is trading 77.8% below its 52-week high of $22. Investors who bought $1,000 worth of OPRX shares 5 years ago would now be looking at an investment worth $97.

OptimizeRx Corporation (OPRX) has returned -59.62% so far this year and -62.56% over the past 12 months. Looking at the last ten years, OPRX has achieved an annualized return of 16.13%, outperforming the S&P 500 Index benchmark, which averaged 13.66% per year.

Based on dividend-adjusted daily data since Jul 13, 2007, OPRX's average daily return is +21.51%, while the average monthly return is +457.21%. At this rate, an investment would double in approximately 0.0 years.

Historically, 45% of months were positive and 55% were negative. The best month was Apr 2008 with a return of +103,650.0%, while the worst month was Nov 2007 at -80.0%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 9 months.

On a daily basis, OPRX closed higher 38% of trading days. The best single day was Apr 28, 2008 with a return of +99,900.0%, while the worst single day was Jun 5, 2009 at -74.1%.

OptimizeRx Corporation has an annualized alpha of 235160278887669128232960.00%, beta of -1.28, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since July 16, 2007.

• This stock captured 145.19% of S&P 500 Index gains and 116.58% of its losses - amplifying both gains and losses, but participating more in upside than downside.
• Beta of -1.28 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

OPRX ranks 9 for risk / return — in the bottom 9% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for OptimizeRx Corporation (OPRX) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the OptimizeRx Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the OptimizeRx Corporation was 99.32%, occurring on Nov 29, 2007. Recovery took 102 trading sessions.

The current OptimizeRx Corporation drawdown is 94.95%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of OptimizeRx Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how OptimizeRx Corporation is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.